AMENDMENT NO. 4 TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • May 9th, 2019 • Ani Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMay 9th, 2019 Company IndustryThis Amendment No. 4 to Asset Purchase Agreement (the "Amendment") is dated as of January 30, 2019 (the "Effective Date") and is by and between Teva Pharmaceuticals USA, Inc., a Delaware corporation (collectively, "Teva"), on the one hand, and ANI Pharmaceuticals, Inc., a Delaware corporation ("Buyer") on the other hand.